Stay updated with breaking news from Robert Stockley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The researchers made the interesting finding using a trial involving patients with a rare genetic condition called Alpha-1 antitrypsin deficiency (AATD).
Patients with lung disease are more likely to develop heart disease independent of any risk factors, according to new research.
LONDON, May 23, 2023 -- Mereo BioPharma Group plc , a clinical-stage biopharmaceutical company focused on rare diseases today announced that data from the Phase 2 “ASTRAEUS” trial of... | May 23, 2023
LONDON, May 23, 2023 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or “the Company”), a clinical-stage biopharmaceutical company...
LONDON, March 28, 2023 -- Mereo BioPharma Group plc , a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the year ended December 31,... | March 28, 2023